NCT07461181 2026-03-10A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid TumorsRuijin HospitalPhase 1/2 Active not recruiting10 enrolled